Protein Kinase p70 (S6K) inhibitor
Catalog No. R21-901
Catalog No. | Pack Size | Price (USD) | |
---|---|---|---|
R21-901-1 | 1 mg | $75 | |
R21-901-05 | 5 mg | $305 | |
R21-901-BULK | BULK | Contact Us |
Overview:
This bis indolylmaleimide derivative is a potent inhibitor of the mitogen-stimulated protein kinase p70 (S6K) acting independently of its upstream activator mTOR1. Does not inhibit PKC (at concentrations <100 µM) and therefore may also be used as a negative control for bisindolylmaleimide PKC inhibitors2 such as GF 109203X3 and other structurally related inhibitors4
References:
1. N Marmy-Conus et al. FEBS Lett. 2002 519:135
2. CS Harmon et al. Skin Pharmacol. 1997 10:71
3. D Toullec et al. J. Biol. Chem. 1991 266:15771
4. PD Davis et al. J. Med. Chem. 1992 35:177
CAS Registry Number:
113963-68-1
Molecular Formula:
C21H15N3O2
Appearance:
Orange powder
Molecular Weight:
341.4
Purity:
>98% (HPLC, TLC); NMR (conforms)
Solubilization:
May be dissolved in DMSO (35 mg/ml); or ethanol (9 mg/ml)
Aliases:
1-Methyl-3,4-bis(indol-3-yl)maleimide; Bisindolylmaleimide V; BIM V
Storage and Stability:
Store desiccated as supplied at -20oC for up to 2 years. Store solutions at -20oC for up to 3 months.
Molecular Structure:
There are no related publications available for this product.
AKT/PKB Pathway, Angiogenesis, Apoptosis/Autophagy, Cancer, Cardiovascular Disease, Inflammation, Metabolic Disorder, Ser/Thr Kinases
STAY CONNECTED
Fax: 1-604-232-4601